Ignite Creation Date:
2024-05-05 @ 12:11 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00260364
Status:
COMPLETED
Last Update Posted:
2016-10-14
First Post:
2005-11-29
Brief Title:
Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic Cancer
Sponsor:
Royal Marsden NHS Foundation Trust
Organization:
Royal Marsden NHS Foundation Trust
Organization Data
Organization:
Royal Marsden NHS Foundation Trust
Class:
OTHER
Study ID:
CCR2631
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Hoffmann-La Roche | INDUSTRY |
| Professor Cunninghams Clinical Research Fund | UNKNOWN |